期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

单中心IgA肾病高尿酸血症患病率及其临床病理特点分析 被引量：5

下载PDF
导出
摘要 IgA肾病（IgA nephropathy,IgAN）是目前临床最常见的原发性肾小球疾病之一,占我国原发性肾小球疾病的45%,也是导致终末期肾病（end stage renal disease,ESRD）的重要病因之一[1]。多种因素参与了IgAN的进展[2],而高血压、肾功能受损、高级别病理分级、尿蛋白〉1g/24h是公认的进展因素[3-4]。
作者 芮艳霞 寿张飞
机构地区 浙江大学附属第一医院肾病中心 嘉兴市第一医院肾内科
出处 《解放军医学杂志》 CAS CSCD 北大核心 2016年第6期518-520,共3页 Medical Journal of Chinese People's Liberation Army
关键词 肾小球肾炎 IgA 高尿酸血症 患病率
分类号 R692.31 [医药卫生—泌尿科学]
  • 相关文献

参考文献17

  • 1陈香美,谢院生.重视延缓IgA肾病进展的基础和临床研究[J].中华肾脏病杂志,2004,20(4):235-237. 被引量：155
  • 2周素晗,赵苘,张颖,权松霞,邢国兰.IgA肾病肾组织血管病变分析[J].郑州大学学报（医学版）,2015,50(5):686-689. 被引量：7
  • 3Donadio JV, Grande Jp. IgA nephropathy[J]. N Engl J Med, 2002, 347(10): 738-748.
  • 4Le W, Liang S, Hu Y, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population[J]. Nephrol Dial Transplant, 2012, 27(4): 1479-1485.
  • 5Shi Y, Chen W, Jalal D, et al. Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled, trial[J]. Kidney Blood Press Res, 2012, 35(3): 153-160.
  • 6Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk[J]. N EnglJ Med, 2008, 359(17): 1811-1821.
  • 7Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 37(9): 815-822.
  • 8National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J1. AmJ Kidney Dis, 2002, 39(2): S1-S266.
  • 9Philip Kam, Tao Li, Kelvin Kai, et al. Prognostic indicators of IgA nephropathy in the Chinese: clinical and pathological perspectives[J]. Nephrol Dial Transplant, 2002, 17(1): 64-69.
  • 10李明,余学清.IgA肾病全基因组关联分析研究[J].中国实用内科杂志,2014,34(3):220-222. 被引量：20

二级参考文献33

  • 1Wyatt RJ, Julian BA. IgA nephropathy [J]. N Engl J Med,2013, 368 : 2402 - 2414.
  • 2Barratt J, Feehally J. IgA nephropathy[J]. J Am Soc Nephrol,2005, 16:2088 - 2097.
  • 3Scolari F, Amoroso A, Savoldi S, et al. Familial clustering of IgA ne- phropathy : further evidence in an Italian population [ J ]. Am J Kid- ney Dis, 1999,33 : 857 - 865.
  • 4Schena FP,Cerullo G, Rossini M, et al. increased risk of end-stage renal disease in familial IgA nephropathy [ J]. J Am Soc Nephrol, 2002,13:453 -460.
  • 5Hall YN, Fuentes EF, Chertow GM, et al. Race/ethnicity and dis- ease severity in IgA nephropathy [ J ]. BMC Nephrol,2004,5:10.
  • 6Hoy WE, Hughson MD, Smith SM, et al. Mesangial proliferative glo- merulonephritis in southwestern American Indians[ J ]. Am J Kidney Dis, 1993,21:486 -496.
  • 7Bisceglia L, Cerullo G, Forabosco P, et al. Genetic heterogeneity in Italian families with IgA nephropathy:suggestive linkage for two no- vel IgA nephropathy loci [ J]. Am J Hum Genet,2006,79:1130 - 1134.
  • 8Paterson AD, Liu XQ,Wang K, et al. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility lo- cus to chromosome 2q36 [ J ]. J Am Soc Nephrol, 2007,18 : 2408 - 2415.
  • 9Kiryluk K, Julian BA, Wyatt R J, et al. Genetic studies of IgA ne- phropathy : past, present, and future [ J ]. Pediatr Nephrol, 2010,25 ( 11 ) :2257 - 2268.
  • 10Hardy J, Singleton A. Genomewide association studies and human disease[ J]. N Engl J Med ,2009,360 : 1759 - 1768.

共引文献179

同被引文献31

  • 1燕宇,徐丽霞,张军军,张颖,赵明辉.糖基化异常IgA1自身聚合或与IgG形成的大分子可能与IgA肾病病理表型相关[J].中华微生物学和免疫学杂志,2006,26(10):898-903. 被引量：3
  • 2Sanjeev S, Mark H, Glen SM, et al. Mayo Clinic/Renal Pathologysociety consensus report on pathologic classification; diagnosis, andreporting of GN[J].J Am Soc Nephrol, 2016; 27(5): 1278-1287.
  • 3Cattran DC, Coppo R, Cook HT; et al. WorkingGroup of theInternational IgA Nephropathy Network and the Renal PathologySociety: the Oxford classification of IgA nephropathy: Rationale,clinicopathological correlations, and classification[J]. Kidney Int,2009,76(5):534-545.
  • 4Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmicautoantibody-mediated disease [J]. Nat Rev Rheumatol, 2014, 10(8):463-473.
  • 5Jennette JC, Falk RJ, Bacon PA, et al. Watts RA: 2012 revisedInternational Chapel Hill Consensus Conference Nomenclature ofVasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11.
  • 6Hellmark T; Niles JL, Collins AB, et al. Comparison of anti-GBMantibodies in sera with or without AN CA [ J]. J Am Soc Nephrol; 1997,8(3):376-385.
  • 7Nasr SH, Satoskar A, Markowitz GS, et al. Proliferativeglomerulonephritis with monoclonal IgG deposits[J]. J Am SocNephrol, 2009,20(9): 2055-2064.
  • 8Sethi S, Rajkumar SV. Monoclonal gammopathy-associatedproliferative glomerulonephritis[J]. Mayo Clin Proc, 2013, 88(11):1284-1293.
  • 9PickeringMQ D’Agati VD, Nester CM, et al. C3 glomerulopathy:Consensus report [J], Kidney Int, 2013,84(6): 1079-1089.
  • 10Weening JJ, D’Agati VD, Schwartz MM, et al. The classification ofglomerulonephritis in systemic lupus erythematosus revisited[J].j AmSoc Nephrol, 2004,15(2): 241-250.

引证文献5

二级引证文献28

解放军医学杂志
2016年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部